Literature DB >> 8347847

Mechanisms involved in the metastasis of cancer to bone.

F W Orr1, P Kostenuik, O H Sanchez-Sweatman, G Singh.   

Abstract

The metastasis of cancer to bone is a frequent outcome of common malignancies and is often associated with significant morbidity due to osteolysis. Bone metastasis is also selective in that a disproportionately small number of malignancies account for the majority of tumors which spread to bone. While the mechanisms of bone destruction have been studied, those responsible for the site-specific nature of bone metastasis are poorly understood. As a metastatic target, bone is unique in that it is continuously being remodelled under the influence of local and systemic growth factors, many of which are embedded in the bone matrix. This review summarizes evidence for the hypothesis that the formation of metastatic tumors in bone is the consequence of a unique microenvironment where metastatic cells can alter the metabolism of bone, thereby regulating the release of soluble bone-derived growth factors as a consequence of bone resorption. These, in turn, can modulate the malignant phenotypic properties of receptive cells. Transforming growth factor-beta is one factor which can promote the growth and motility of Walker 256 cells, a rat cell line with a propensity to metastasize spontaneously to bone.

Entities:  

Mesh:

Year:  1993        PMID: 8347847     DOI: 10.1007/bf00662140

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  98 in total

Review 1.  Skeletal tissue and transforming growth factor beta.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  FASEB J       Date:  1988-12       Impact factor: 5.191

2.  Bone marrow involvement in anaplastic small cell lung cancer. Diagnosis, hematologic features, and prognostic implications.

Authors:  W R Bezwoda; D Lewis; N Livini
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

3.  Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.

Authors:  P S Steeg; G Bevilacqua; R Pozzatti; L A Liotta; M E Sobel
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

4.  Fourier analysis of cell motility: correlation of motility with metastatic potential.

Authors:  A W Partin; J S Schoeniger; J L Mohler; D S Coffey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 5.  Structural substrates of bone marrow function.

Authors:  P P De Bruyn
Journal:  Semin Hematol       Date:  1981-07       Impact factor: 3.851

6.  Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.

Authors:  T J Powles; M Dowsett; G C Easty; D M Easty; A M Neville
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

7.  Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors.

Authors:  C S Tam; J N Heersche; A Santora; A M Spiegel
Journal:  Metabolism       Date:  1984-01       Impact factor: 8.694

8.  A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells.

Authors:  P J Kostenuik; G Singh; K L Suyama; F W Orr
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

Review 9.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

10.  An experimental rat model of local bone cancer invasion and its responsiveness to ethane-1-hydroxy-1,1-bis(phosphonate).

Authors:  A Guaitani; M Sabatini; G Coccioli; S Cristina; S Garattini; I Bartosek
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

View more
  9 in total

1.  Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

Authors:  G van der Pluijm; H Vloedgraven; E van Beek; L van der Wee-Pals; C Löwik; S Papapoulos
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Expression of bone sialoprotein and osteopontin in breast cancer bone metastases.

Authors:  T Ibrahim; I Leong; O Sanchez-Sweatman; R Khokha; J Sodek; H C Tenenbaum; B Ganss; S Cheifetz
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.

Authors:  E W Thompson; V Sung; M Lavigne; K Baumann; N Azumi; A D Aaron; R Clarke
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

4.  Human breast cancer cell metastasis to long bone and soft organs of nude mice: a quantitative assay.

Authors:  V Sung; D A Cattell; J M Bueno; A Murray; J A Zwiebel; A D Aaron; E W Thompson
Journal:  Clin Exp Metastasis       Date:  1997-03       Impact factor: 5.150

5.  Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9.

Authors:  Maria Pavlaki; Eleftheria Giannopoulou; Anna Niarakis; Panagiota Ravazoula; Alexios J Aletras
Journal:  Mol Cell Biochem       Date:  2009-03-29       Impact factor: 3.396

6.  A multidisciplinary bone metastases clinic at Toronto Sunnybrook Regional Cancer Centre - A review of the experience from 1999 to 2005.

Authors:  Kathy K Li; Emily Sinclair; Joan Pope; Macey Farhadian; Kristin Harris; Julie Napolskikh; Albert Yee; Lawrence Librach; Lesia Wynnychuk; Cyril Danjoux; Edward Chow; On Behalf Of The Bone; Metastases Team
Journal:  J Pain Res       Date:  2008-09-01       Impact factor: 3.133

7.  Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.

Authors:  E F Solomayer; I J Diel; D Wallwiener; S Bode; G Meyberg; M Sillem; C Gollan; M D Kramer; U Krainick; G Bastert
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  New multidisciplinary prostate bone metastases clinic: first of its kind in Canada.

Authors:  P Goh; K Harris; J Napolskikh; E Chow; E Sinclair; U Emmenegger; S Lemon; A Yee; L Wynnychuk; J Myers; C Danjoux; Y Ko
Journal:  Curr Oncol       Date:  2007-02       Impact factor: 3.677

9.  Comparison of tumor curettage and resection for treatment of giant cell tumor of the bone around the knee joint.

Authors:  Sheng Zhang; Jianhua Zhang; Xin Wang
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.